Two years ago, researchers examining the link between GLP-1 and substance abuse began to publish large, observational studies showing that patients taking GLP-1s for their prescribed purposes incidentally reported less alcohol, opioid, cannabis and cigarette use and had a lower risk of developing a substance use disorder
Journal of managed care & specialty pharmacy , 27 (3), 354-366
This interaction may lead to changes in the receptor's structure, initiating a series of molecular events that may activate signal transduction pathways within the target cells
Concerning that, site-related adverse events, including pain, redness, bleeding, and, especially, bruising, are significant barriers to patient adherence to multiple daily injection regimens
Understanding Zepbound's timeline helps patients and clinicians set realistic expectations for this long-term treatment, which requires commitment to lifestyle modifications alongside medication therapy for optimal outcomes